Related Experiment Videos
TGF-beta 1 and IGF-1 expression in atrophic post-menopausal endometrium
G Loverro1, E Perlino, E Maiorano
1Department of Obstetrics and Gynaecology, School of Medicine, University of Bari, Italy.
Maturitas
|May 5, 1999
Summary
Insulin-like growth factor-1 (IGF-1) and transforming growth factor beta-1 (TGF-beta 1) may maintain the quiescent state of post-menopausal atrophic endometria. Their receptors in the epithelial compartment may influence proliferative responses to hormone therapy.
Area of Science:
- Endocrinology
- Gynecologic Oncology
- Molecular Biology
Background:
- Endometrial cells synthesize cytokines and growth factors influencing proliferation and differentiation.
- Post-menopausal atrophic endometrium represents a unique cellular environment.
Purpose of the Study:
- To investigate the roles of transforming growth factor beta-1 (TGF-beta 1) and insulin-like growth factor-1 (IGF-1) and their receptors in atrophic post-menopausal endometria.
- To compare these factors in atrophic endometria with proliferative and secretory endometria.
Main Methods:
- Analysis of five atrophic post-menopausal endometrial tissue samples and ten control samples (proliferative and secretory).
- Quantification of TGF-beta 1 and IGF-1 messenger RNA (mRNA) expression using Northern hybridization.
- Immunohistochemical localization of TGF-beta 1 and IGF-1 receptors.
Main Results:
- Atrophic endometria showed significantly decreased IGF-1 mRNA expression and increased TGF-beta 1 mRNA expression compared to controls.
- TGF-beta 1 and IGF-1 receptors were localized in the cytoplasm of endometrial cells, predominantly in the stromal compartment.
Conclusions:
- IGF-1 and TGF-beta 1 may play a role in maintaining the quiescent, differentiated state of the atrophic post-menopausal endometrium.
- The presence of IGF-1 and TGF-beta 1 receptors in the epithelial compartment suggests a potential role in the proliferative response to hormone replacement therapy or elevated estrogen levels.